MGCD-265 analog

• Target :

  Apoptosis|||VEGFR|||c-Met/HGFR

• Related Pathways :

  Apoptosis|||Angiogenesis|||Tyrosine Kinase/Adaptors

• Purity :

  0.9921

• Bioactivity :

  MGCD-265 analog (Glesatinib) is an orally bioavailable multitargeted tyrosine kinase inhibitor with potential antineoplastic activity with IC50 of 29 nM and 10 nM for c-Met and VEGFR2, respectively.

• Smiles :

  Cn1cnc(c1)-c1cc2nccc(Oc3ccc(NC(=S)NC(=O)Cc4ccccc4)cc3F)c2s1

• Molecular Formula :

  C26H20FN5O2S2

• Molecular Weight :

  517.6

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  875337-44-3